Registration - In-house Corporation

BioVectra Inc. / Oliver Technow, Chief Executive Officer

Registration Information

In-house Corporation name: BioVectra Inc.
Responsible Officer Name: Oliver Technow, Chief Executive Officer
Initial registration start date: 2017-10-09
Registration status: Active
Registration Number: 859732-361154

Associated Communications

Total Number of Communication Reports: 0

Monthly communication reports in the last 6 months: 0

Version 9 of 13 (2021-04-29 to 2022-02-24)

Registration versions:

Version 9 of 13 (2021-04-29 to 2022-02-24)

Lobbying Information

Subject Matters

Economic Development

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Seeking funding to allow the corporation to expand API and scaled biologics capacity in the Atlantic Region from Canada’s Strategic Innovation Fund (SIF). In March 2020, BioVectra Inc. was granted $21.1M in the form of grants and conditionally repayable loans.

Communication Techniques

Written communication
Oral communication

Government Institutions

Atlantic Canada Opportunities Agency (ACOA)
Canada Revenue Agency (CRA)
Innovation, Science and Economic Development Canada (ISED)
National Research Council (NRC)

In-house Corporation Details

Description of activities

BioVectra is a contract development and manufacturing organization (CDMO) that serves pharmaceutical and biotech companies with full-service Current Good Manufacturing Practice (cGMP) outsourcing solutions for intermediates and active pharmaceutical ingredients (APIs).

Responsible officer name and position during the period of this registration

Oliver Technow, Chief Executive Officer

Government funding

End date of the last completed financial year: 2020-12-31

List of Government Funding
Government Institution	Funding Received in Last Financial Year	Funding Expected in Current Financial Year
Atlantic Canada Opportunities Agency (ACOA)	$478,981.00	Yes
Biotalent Canada	$69,187.45	Yes
Innovation PEI	$600,000.00	Yes
Labor Market Development Program -Skills PEI	$48,998.44	Yes
National Research Council (NRC)	$96,654.91	Yes
Nova Scotia Business Inc wage rebate (Nova Scotia)	$364,750.00	No
Province of PEI - COVID Funding	$24,710.00	No
Réseau de développement économique et d’employabilité (RDEE) PEI - Wage Rebate	$2,700.00	No
Réseau de développement économique et d’employabilité (RDEE) PEI - Wage Rebate	$2,700.00	No

In-house Corporation Contact Information

Address:
11 Aviation Avenue
Charlottetown, PE C1E 0A1
Canada

Telephone number: 902-566-9116
Fax number: 902-628-2045

Parent Company Information

102374 PEI Inc.
- 97 Queen Street, Suite 600,
  Charlottetown, PE C1A 4A9
  Canada

Subsidiary Beneficiary Information

BioVectra Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Valana Deighan, General Counsel | No public offices held
Heather Delage, Chief Commercial Officer | No public offices held
Scott Doncaster, VP, Manufacturing Technologies & Engineering | No public offices held
David Long, Chief Financial Officer | No public offices held
Marc Sauer, Vice President & GM, Process Science & Development Services | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Oliver Technow, Chief Executive Officer | No public offices held

BioVectra Inc./

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
BioVectra Inc./	2024-07-25	current
BioVectra Inc./	2017-10-09	2024-07-25

BioVectra Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

BioVectra Inc. / Oliver Technow, Chief Executive Officer

Registration Information

Associated Communications

Version 9 of 13 (2021-04-29 to 2022-02-24)

Version 9 of 13 (2021-04-29 to 2022-02-24)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Registration - In-house Corporation

BioVectra Inc. / Oliver Technow, Chief Executive Officer

Version 9 of 13 (2021-04-29 to 2022-02-24)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

BioVectra Inc./

The following names have been used on or after July 2, 2008

BioVectra Inc.

Oliver Technow, Chief Executive Officer (Corporation)